### 5503 Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices

Drug Schedule

Dextropropoxyphene, bulk (non-dosage forms) (9273) ............................................................................. ................................................. II Morphine (9300) ................................................................................................................ .......................................................................... II Thebaine (9333) ................................................................................................................ .......................................................................... II Levo-alphacetylmethadol (9648) ................................................................................................. ................................................................ II Oxymorphone (9652) ............................................................................................................. ...................................................................... II Noroxymorphone (9668) .......................................................................................................... .................................................................... II Racemethorphan (9732) .......................................................................................................... .................................................................... II Alfentanil (9737) .............................................................................................................. ............................................................................ II Remifentanil (9739) ............................................................................................................ ......................................................................... II Sufentanil (9740) .............................................................................................................. ........................................................................... II Carfentanil (9743) ............................................................................................................. ........................................................................... II Tapentadol (9780) .............................................................................................................. ......................................................................... II Fentanyl (9801) ................................................................................................................ ........................................................................... II

The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their
customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cerilliant Corporation to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cerilliant Corporation to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems; verification of the company’s compliance with state and local laws; and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: January 15, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2013–01533 Filed 1–24–13; 8:45 am]

**BILLING CODE 4410–09–P**

**DEPARTMENT OF JUSTICE**

**Drug Enforcement Administration**

**Manufacturer of Controlled Substances, Notice of Registration;**  **Morton Grove Pharmaceuticals**

By Notice dated September 25, 2012, and published in the Federal Register on October 2, 2012, 77 FR 60144, Morton Grove Pharmaceuticals, 6451 Main Street, Morton Grove, Illinois 60053–2633, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class of controlled substance listed in schedule I.

The company plans to manufacture the listed controlled substance for distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a), and determined that the registration of Morton Grove Pharmaceuticals to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Morton Grove Pharmaceuticals to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems; verification of the company’s compliance with state and local laws; and a review of the company’s background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed.

Dated: January 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2013–01592 Filed 1–24–13; 8:45 am]

**BILLING CODE 4410–09–P DEPARTMENT OF LABOR** 

**Office of the Secretary**

**Agency Information Collection Activities; Submission for OMB**  **Review; Comment Request; Statement of Expenditures and Financial**  **Adjustment of Federal Funds for Unemployment Compensation for** **Federal Employees and Ex Servicemembers** 

**ACTION :**  Notice.

**SUMMARY :**  The Department of Labor (DOL) is submitting the Employment and Training Administration (ETA) sponsored information collection request (ICR) titled, ‘‘Statement of Expenditures and Financial Adjustment of Federal Funds for Unemployment Compensation for Federal Employees and Ex-Servicemembers,’’ (Reporting Form ETA–191) to the Office of Management and Budget (OMB) for review and approval for continued use in accordance with the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501 et seq.).

**DATES :**  Submit comments on or before February 25, 2013.

**ADDRESSES :**  A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained from the RegInfo.gov Web site, http://www.reginfo.gov/ public/do/PRAMain, on the day following publication of this notice or by contacting Michel Smyth by telephone at 202–693–4129 (this is not a toll-free number) or sending an email
to DOL

_PRA

_PUBLIC@dol.gov. Submit comments about this request to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL–ETA, Office of Management and Budget, Room 10235, 725 17th Street NW., Washington, DC 20503, Fax: 202–395–6881 (this is not a


### 5504 Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices

toll-free number), email: OIRA

_ submission@omb.eop.gov.

**FOR FURTHER INFORMATION CONTACT :**  Contact Michel Smyth by telephone at 202–693–4129 (this is not a toll-free number) or by email at DOL

_PRA

_PUBLIC@dol.gov.
Authority: 44 U.S.C. 3507(a)(1)(D).

**SUPPLEMENTARY INFORMATION :**  Federal civilian and military agencies must reimburse the Federal Employees Compensation Account for the amount expended for benefits to former Federalcivilian employees and exservicemembers. The ETA–191 report informs the ETA of the amount to bill such agencies.

This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless it is approved by the OMB under the PRA and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid Control Number. See 5 CFR 1320.5(a) and 1320.6. The DOL obtains OMB approval for this information collection under Control Number 1205–0162. The current approval is scheduled to expire on January 31, 2013; however, it should be noted that existing information collection requirements submitted to the OMB receive a month-to-month extension while they undergo review. For additional information, see the related notice published in the Federal Register on September 18, 2012.

Interested parties are encouraged to send comments to the OMB, Office of Information and Regulatory Affairs at the address shown in the **ADDRESSES** section within 30 days of publication of this notice in the Federal Register . In order to help ensure appropriate consideration, comments should mention OMB Control Number 1205– 0162. The OMB is particularly interested in comments that:

• Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

• Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and

• Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of
responses.

Agency: DOL–ETA. Title of Collection: Statement of Expenditures and Financial Adjustment of Federal Funds for Unemployment Compensation for Federal Employees and Ex-Servicemembers.

OMB Control Number: 1205–0162. Affected Public: State, Local, and Tribal Governments.

Total Estimated Number of Respondents: 53.

Total Estimated Number of Responses: 212.

Total Estimated Annual Burden Hours: 1,272.

Total Estimated Annual Other Costs Burden: $0.

Dated: January 17, 2013. Michel Smyth, Departmental Clearance Officer.
[FR Doc. 2013–01513 Filed 1–24–13; 8:45 am]

**BILLING CODE 4510–FW–P**

**OFFICE OF THE DIRECTOR OF NATIONAL INTELLIGENCE** 

**Agency Information Collection Activities: Extension of Information**  **Collection; Comment Request**

**AGENCY :**  Office of the Director of National Intelligence (ODNI).

**ACTION :**  Notice and comment.

**SUMMARY :**  In December 2011, the ODNI accepted responsibility from the Information Security Oversight Office (ISOO) for the maintenance of Standard Form 312: Classified Information Nondisclosure Agreement; Standard Form 713: Consent For Access to Records; and Standard Form 714: Financial Disclosure Report, which are directly related to responsibilities assigned to the Director of National Intelligence (DNI) as Security Executive Agent. Accordingly, ODNI is giving public notice regarding extension of the currently approved information collection, Financial Disclosure Report, Standard Form 714, which candidates for national security clearance must submit as a condition of access to specifically designated classified information along with a favorably adjudicated personnel security background investigation or reinvestigation that results in the granting or updating of a security clearance. ODNI is proposing no changes to the Standard Form 714 and its instructions at this time. The public is invited to comment on the information collection pursuant to the Paperwork Reduction Act of 1995.

**DATES :**  Written comments must be received on or before March 26, 2013 to be assured of consideration.

**ADDRESSES :**  Comments should be sent
to: dni-foia@dni.gov.

**FOR FURTHER INFORMATION CONTACT :**  Requests for additional information or copies of the information collection and supporting statement should be directed to Mr. John Hackett, Office of the Chief Information Officer, Information and Data Management Group, Office of the Director of National Intelligence, Washington, DC 20511.

**SUPPLEMENTARY INFORMATION :**  Pursuant to the Paperwork Reduction Act of 1995 (Pub. L. 104–13), ODNI invites the general public and other Federal agencies to comment on Standard Form 714. The comments and suggestions should address one or more of the following points: (a) Whether the proposed information collection reflected in the Standard Form 714 meets the intent of § 1.3 (‘‘Financial Disclosure’’) of Executive Order 12968 (‘‘Access to Classified Information’’); (b) the accuracy of the estimated burden of the proposed information collection for Standard Form 714; (c) ways to enhance the quality, utility, and clarity of the information to be collected in the Standard Form 714; (d) ways, including the use of information technology, to minimize the burden of the collection of information on all respondents to the Standard Form 714; and (e) whether small businesses are affected by this collection. The comments that are submitted will be summarized and included in the ODNI request for Office of Management and Budget (OMB) approval. All comments will become a matter of public record.

Abstract: The National Security Act of 1947, as amended by the Intelligence Reform and Terrorism Prevention Act of 2004, and Executive Order 13467, ‘‘Reforming Processes Related to Suitability for Government Employment, Fitness for Contractor Employees, and Eligibility for Access to Classified National Security Information,’’ authorizes the DNI as the Security Executive Agent to develop standard forms that promote uniformity and consistency in the implementation